Related Experiment Video
Updated: May 14, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights
Samuele De Minicis1, Chris Day, Gianluca Svegliati-Baroni
1Department of Gastroenterology, Universita Politecnica delle Marche, Italy.
Abstract:
NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Pharmacogenomics: Identification of New Drug Targets
Chronic Pancreatitis II: Pathophysiology
Hepatitis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
